James T. Craig, D.D.S.; Decision and Order, 9169-9170 [2025-02341]

Download as PDF Federal Register / Vol. 90, No. 25 / Friday, February 7, 2025 / Notices pursuant to 28 CFR 0.100(b) and the authority vested in me by 21 U.S.C. 823(g)(1), I hereby deny any pending applications of Herold Pierre-Louis, P.A., to renew or modify this registration, as well as any other pending application of Herold PierreLouis, P.A., for additional registration in Arizona. This Order is effective March 10, 2025. Signing Authority This document of the Drug Enforcement Administration was signed on January 31, 2025, by Acting Administrator Derek Maltz. That document with the original signature and date is maintained by DEA. For administrative purposes only, and in compliance with requirements of the Office of the Federal Register, the undersigned DEA Federal Register Liaison Officer has been authorized to sign and submit the document in electronic format for publication, as an official document of DEA. This administrative process in no way alters the legal effect of this document upon publication in the Federal Register. Heather Achbach, Federal Register Liaison Officer, Drug Enforcement Administration. [FR Doc. 2025–02339 Filed 2–6–25; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration James T. Craig, D.D.S.; Decision and Order lotter on DSK11XQN23PROD with NOTICES1 On May 24, 2023, the Drug Enforcement Administration (DEA or Government) issued an Order to Show Cause (OSC) to James T. Craig, D.D.S., of Aurora, Colorado (Registrant). Request for Final Agency Action (RFAA), Exhibit (RFAAX) 2, at 1, 3. The OSC proposed the revocation of Registrant’s Certificate of Registration No. FC0032348, alleging that Registrant’s registration should be revoked because Registrant is ‘‘currently without authority to prescribe, administer, dispense, or otherwise handle controlled substances in Colorado, the state in which [he is] registered with DEA.’’ Id. at 2 (citing 21 U.S.C. 824(a)(3)).1 1 According to Agency records, Registrant’s registration expired on August 31, 2024. The fact that a registrant allows his registration to expire during the pendency of an OSC does not impact the Agency’s jurisdiction or prerogative under the Controlled Substances Act (CSA) to adjudicate the OSC to finality. Jeffrey D. Olsen, M.D., 84 FR 68474, 68476–79 (2019). VerDate Sep<11>2014 16:22 Feb 06, 2025 Jkt 265001 The OSC notified Registrant of his right to file a written request for hearing, and that if he failed to file such a request, he would be deemed to have waived his right to a hearing and be in default. Id. at 2 (citing 21 CFR 1301.43). Here, Registrant did not request a hearing. RFAA, at 2.2 ‘‘A default, unless excused, shall be deemed to constitute a waiver of the registrant’s/applicant’s right to a hearing and an admission of the factual allegations of the [OSC].’’ 21 CFR 1301.43(e). Further, ‘‘[i]n the event that a registrant . . . is deemed to be in default . . . DEA may then file a request for final agency action with the Administrator, along with a record to support its request. In such circumstances, the Administrator may enter a default final order pursuant to [21 CFR] § 1316.67.’’ Id. § 1301.43(f)(1). Here, the Government has requested final agency action based on Registrant’s default pursuant to 21 CFR 1301.43(c), (f), 1301.46. RFAA, at 3; see also 21 CFR 1316.67. Findings of Fact The Agency finds that, in light of Registrant’s default, the factual allegations in the OSC are admitted. According to the OSC, on March 23, 2023, Registrant’s Colorado dental license was suspended. RFAAX 2, at 1– 2. According to Colorado online records, of which the Agency takes official notice, Registrant’s Colorado dentist license is revoked.3 Colorado Division of Professions and Occupations License Search, https://apps2.colorado.gov/ dora/licensing/lookup/licenselookup. aspx (last visited date of signature of this Order). 2 Based on the Government’s submissions in its RFAA dated July 18, 2024, the Agency finds that service of the OSC on Registrant was adequate. Specifically, the included Declaration from a DEA Diversion Investigator (DI) indicates that on May 26, 2023, Registrant was personally served a copy of the OSC at the Arapahoe County Detention Center in Centennial, Colorado, where Registrant remained incarcerated. RFAAX 3, at 2. 3 Under the Administrative Procedure Act, an agency ‘‘may take official notice of facts at any stage in a proceeding—even in the final decision.’’ United States Department of Justice, Attorney General’s Manual on the Administrative Procedure Act 80 (1947) (Wm. W. Gaunt & Sons, Inc., Reprint 1979). Pursuant to 5 U.S.C. 556(e), ‘‘[w]hen an agency decision rests on official notice of a material fact not appearing in the evidence in the record, a party is entitled, on timely request, to an opportunity to show the contrary.’’ Accordingly, Registrant may dispute the Agency’s finding by filing a properly supported motion for reconsideration of findings of fact within fifteen calendar days of the date of this Order. Any such motion and response shall be filed and served by email to the other party and to the DEA Office of the Administrator, Drug Enforcement Administration at dea.addo.attorneys@dea.gov. PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 9169 Accordingly, the Agency finds that Registrant is not licensed to practice as a dentist in Colorado, the state in which he is registered with DEA. Discussion Pursuant to 21 U.S.C. 824(a)(3), the Attorney General is authorized to suspend or revoke a registration issued under 21 U.S.C. 823 ‘‘upon a finding that the registrant . . . has had his State license or registration suspended . . . [or] revoked . . . by competent State authority and is no longer authorized by State law to engage in the . . . dispensing of controlled substances.’’ With respect to a practitioner, DEA has also long held that the possession of authority to dispense controlled substances under the laws of the state in which a practitioner engages in professional practice is a fundamental condition for obtaining and maintaining a practitioner’s registration. Gonzales v. Oregon, 546 U.S. 243, 270 (2006) (‘‘The Attorney General can register a physician to dispense controlled substances ‘if the applicant is authorized to dispense . . . controlled substances under the laws of the State in which he practices.’ . . . The very definition of a ‘practitioner’ eligible to prescribe includes physicians ‘licensed, registered, or otherwise permitted, by the United States or the jurisdiction in which he practices’ to dispense controlled substances. § 802(21).’’). The Agency has applied these principles consistently. See, e.g., James L. Hooper, M.D., 76 FR 71371, 71372 (2011), pet. for rev. denied, 481 F. App’x 826 (4th Cir. 2012); Frederick Marsh Blanton, M.D., 43 FR 27616, 27617 (1978).4 According to Colorado statute, ‘‘dispense’’ means ‘‘to deliver a controlled substance to an ultimate user, 4 This rule derives from the text of two provisions of the CSA. First, Congress defined the term ‘‘practitioner’’ to mean ‘‘a physician . . . or other person licensed, registered, or otherwise permitted, by . . . the jurisdiction in which he practices . . . , to distribute, dispense, . . . [or] administer . . . a controlled substance in the course of professional practice.’’ 21 U.S.C. 802(21). Second, in setting the requirements for obtaining a practitioner’s registration, Congress directed that ‘‘[t]he Attorney General shall register practitioners . . . if the applicant is authorized to dispense . . . controlled substances under the laws of the State in which he practices.’’ 21 U.S.C. 823(g)(1). Because Congress has clearly mandated that a practitioner possess state authority in order to be deemed a practitioner under the CSA, DEA has held repeatedly that revocation of a practitioner’s registration is the appropriate sanction whenever he is no longer authorized to dispense controlled substances under the laws of the state in which he practices. See, e.g., James L. Hooper, M.D., 76 FR 71371–72; Sheran Arden Yeates, M.D., 71 FR 39130, 39131 (2006); Dominick A. Ricci, M.D., 58 FR 51104, 51105 (1993); Bobby Watts, M.D., 53 FR 11919, 11920 (1988); Frederick Marsh Blanton, M.D., 43 FR 27617. E:\FR\FM\07FEN1.SGM 07FEN1 9170 Federal Register / Vol. 90, No. 25 / Friday, February 7, 2025 / Notices patient, or research subject by or pursuant to the lawful order of a practitioner, including the prescribing, administering, packaging, labeling, or compounding necessary to prepare the substance for that delivery.’’ Colo. Rev. Stat. section 18–18–102(9) (2024). Further, a ‘‘practitioner’’ means a ‘‘physician . . . or other person licensed, registered, or otherwise permitted, by this state, to distribute, dispense, conduct research with respect to, administer, or to use in teaching or chemical analysis, a controlled substance in the course of professional practice or research.’’ Id. section 18–18– 102(29). Here, the undisputed evidence in the record is that Registrant lacks authority to practice as a dentist in Colorado. As discussed above an individual must be a licensed practitioner to dispense a controlled substance in Colorado. Thus, because Registrant lacks authority to practice as a dentist in Colorado and, therefore, is not authorized to handle controlled substances in Colorado, Registrant is not eligible to maintain a DEA registration. Accordingly, the Agency will order that Registrant’s DEA registration be revoked. Order Pursuant to 28 CFR 0.100(b) and the authority vested in me by 21 U.S.C. 824(a), I hereby revoke DEA Certificate of Registration No. FC0032348, issued to James T. Craig, D.D.S. Further, pursuant to 28 CFR 0.100(b) and the authority vested in me by 21 U.S.C. 823(g)(1), I hereby deny any pending applications of James T. Craig, D.D.S., to renew or modify this registration, as well as any other pending application of James T. Craig, D.D.S., for additional registration in Colorado. This Order is effective March 10, 2025. lotter on DSK11XQN23PROD with NOTICES1 Signing Authority This document of the Drug Enforcement Administration was signed on January 31, 2025, by Acting Administrator Derek Maltz. That document with the original signature and date is maintained by DEA. For administrative purposes only, and in compliance with requirements of the Office of the Federal Register, the undersigned DEA Federal Register Liaison Officer has been authorized to sign and submit the document in electronic format for publication, as an official document of DEA. This administrative process in no way alters VerDate Sep<11>2014 16:22 Feb 06, 2025 Jkt 265001 the legal effect of this document upon publication in the Federal Register. Heather Achbach, Federal Register Liaison Officer, Drug Enforcement Administration. [FR Doc. 2025–02341 Filed 2–6–25; 8:45 am] BILLING CODE 4410–09–P NATIONAL SCIENCE FOUNDATION Sunshine Act Meetings The National Science Board’s Committee on Awards and Facilities (A&F) hereby gives notice of the scheduling of meetings for the transaction of National Science Board business pursuant to the National Science Foundation Act and the Government in the Sunshine Act. TIME AND DATE: The A&F meeting will be held on Monday, February 10, 2025. The open session will be from 2:30 p.m.–3:00 p.m. The closed session will be from 3:00 p.m.–5:00 p.m. PLACE: The meetings will be held at NSF headquarters, 2145 Eisenhower Ave., Alexandria, VA 22314, and by videoconference. STATUS: One session is open, and one session is closed. MATTERS TO BE CONSIDERED: A&F open session agenda: Opening Remarks; Information Item: Summit Station Recapitalization. A&F closed session agenda: Opening Remarks regarding the agenda; Discussion and Vote: National Radio Astronomy Observatory Operations and Maintenance Award Authorization Level Increase; Context Item: Mid-scale Research Infrastructure Program Track 2; Context Item: National Geophysical Facility. CONTACT PERSON FOR MORE INFORMATION: Point of contact for this meeting is: Michelle McCrackin, mmccrack@ nsf.gov, (703) 292–7000. Members of the public can observe the public portion of this meeting through a YouTube livestream: https://youtube.com/live/ 45FMoMrZar8?feature=share. Ann E. Bushmiller, Senior Legal Counsel to the National Science Board. [FR Doc. 2025–02403 Filed 2–5–25; 11:15 am] BILLING CODE 7555–01–P NEIGHBORHOOD REINVESTMENT CORPORATION 2:00 p.m., Thursday, February 18, 2025. PO 00000 Frm 00038 Fmt 4703 Sfmt 9990 STATUS: Agenda I. Call to Order II. Sunshine Act Approval of Executive (Closed) Session III. Executive Session: CEO Report IV. Executive Session: CFO Report V. Executive Session: General Counsel Report VI. Executive Session: CIO Report VII. Action Item: Approval of Meeting Minutes for December 19 Regular Board Meeting VIII. Action Item: Resolution of Recognition of Service for Former FDIC Chairman Gruenberg IX. Action Item: Resolution of Recognition of Service for Former Acting HUD Secretary Todman X. Discussion Item: National NeighborWorks Association Presentation XI. Discussion Item: Capital Corporations Presentation XII. Discussion Item: Health Insurance Delegation of Authority XIII. Discussion Item: Professional Learning and Event Planning Management System (PLEMS) XIV. Discussion Item: Management Program Background and Updates a. 2025 Board Calendar b. 2025 Board Agenda Planner c. CFO Report i. Financials (through 11/30/24) ii. Single Invoice Approvals $100K and over iii. Vendor Payments $350K and over iv. Exceptions d. Housing Stability Counseling Program (HSCP) e. Strategic Plan Scorecard—FY24 Q4 (With Q4 Production) PORTIONS OPEN TO THE PUBLIC: Everything except the Executive (Closed) Session. PORTIONS CLOSED TO THE PUBLIC: Executive (Closed) Session. CONTACT PERSON FOR MORE INFORMATION: Jenna Sylvester, Paralegal, (202) 568– 2560; jsylvester@nw.org. Jenna Sylvester, Paralegal. Sunshine Act Meetings TIME AND DATE: via ZOOM. Parts of this meeting will be open to the public. The rest of the meeting will be closed to the public. MATTERS TO BE CONSIDERED: Regular Board of Directors meeting. The General Counsel of the Corporation has certified that in her opinion, one or more of the exemptions set forth in the Government in the Sunshine Act, 5 U.S.C. 552b(c)(2) permit closure of the following portion(s) of this meeting: • Executive (Closed) Session PLACE: [FR Doc. 2025–02391 Filed 2–5–25; 11:15 am] BILLING CODE 7570–01–P E:\FR\FM\07FEN1.SGM 07FEN1

Agencies

[Federal Register Volume 90, Number 25 (Friday, February 7, 2025)]
[Notices]
[Pages 9169-9170]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-02341]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


James T. Craig, D.D.S.; Decision and Order

    On May 24, 2023, the Drug Enforcement Administration (DEA or 
Government) issued an Order to Show Cause (OSC) to James T. Craig, 
D.D.S., of Aurora, Colorado (Registrant). Request for Final Agency 
Action (RFAA), Exhibit (RFAAX) 2, at 1, 3. The OSC proposed the 
revocation of Registrant's Certificate of Registration No. FC0032348, 
alleging that Registrant's registration should be revoked because 
Registrant is ``currently without authority to prescribe, administer, 
dispense, or otherwise handle controlled substances in Colorado, the 
state in which [he is] registered with DEA.'' Id. at 2 (citing 21 
U.S.C. 824(a)(3)).\1\
---------------------------------------------------------------------------

    \1\ According to Agency records, Registrant's registration 
expired on August 31, 2024. The fact that a registrant allows his 
registration to expire during the pendency of an OSC does not impact 
the Agency's jurisdiction or prerogative under the Controlled 
Substances Act (CSA) to adjudicate the OSC to finality. Jeffrey D. 
Olsen, M.D., 84 FR 68474, 68476-79 (2019).
---------------------------------------------------------------------------

    The OSC notified Registrant of his right to file a written request 
for hearing, and that if he failed to file such a request, he would be 
deemed to have waived his right to a hearing and be in default. Id. at 
2 (citing 21 CFR 1301.43). Here, Registrant did not request a hearing. 
RFAA, at 2.\2\ ``A default, unless excused, shall be deemed to 
constitute a waiver of the registrant's/applicant's right to a hearing 
and an admission of the factual allegations of the [OSC].'' 21 CFR 
1301.43(e).
---------------------------------------------------------------------------

    \2\ Based on the Government's submissions in its RFAA dated July 
18, 2024, the Agency finds that service of the OSC on Registrant was 
adequate. Specifically, the included Declaration from a DEA 
Diversion Investigator (DI) indicates that on May 26, 2023, 
Registrant was personally served a copy of the OSC at the Arapahoe 
County Detention Center in Centennial, Colorado, where Registrant 
remained incarcerated. RFAAX 3, at 2.
---------------------------------------------------------------------------

    Further, ``[i]n the event that a registrant . . . is deemed to be 
in default . . . DEA may then file a request for final agency action 
with the Administrator, along with a record to support its request. In 
such circumstances, the Administrator may enter a default final order 
pursuant to [21 CFR] Sec.  1316.67.'' Id. Sec.  1301.43(f)(1). Here, 
the Government has requested final agency action based on Registrant's 
default pursuant to 21 CFR 1301.43(c), (f), 1301.46. RFAA, at 3; see 
also 21 CFR 1316.67.

Findings of Fact

    The Agency finds that, in light of Registrant's default, the 
factual allegations in the OSC are admitted. According to the OSC, on 
March 23, 2023, Registrant's Colorado dental license was suspended. 
RFAAX 2, at 1-2. According to Colorado online records, of which the 
Agency takes official notice, Registrant's Colorado dentist license is 
revoked.\3\ Colorado Division of Professions and Occupations License 
Search, https://apps2.colorado.gov/dora/licensing/lookup/licenselookup.aspx (last visited date of signature of this Order).
---------------------------------------------------------------------------

    \3\ Under the Administrative Procedure Act, an agency ``may take 
official notice of facts at any stage in a proceeding--even in the 
final decision.'' United States Department of Justice, Attorney 
General's Manual on the Administrative Procedure Act 80 (1947) (Wm. 
W. Gaunt & Sons, Inc., Reprint 1979). Pursuant to 5 U.S.C. 556(e), 
``[w]hen an agency decision rests on official notice of a material 
fact not appearing in the evidence in the record, a party is 
entitled, on timely request, to an opportunity to show the 
contrary.'' Accordingly, Registrant may dispute the Agency's finding 
by filing a properly supported motion for reconsideration of 
findings of fact within fifteen calendar days of the date of this 
Order. Any such motion and response shall be filed and served by 
email to the other party and to the DEA Office of the Administrator, 
Drug Enforcement Administration at [email protected].
---------------------------------------------------------------------------

    Accordingly, the Agency finds that Registrant is not licensed to 
practice as a dentist in Colorado, the state in which he is registered 
with DEA.

Discussion

    Pursuant to 21 U.S.C. 824(a)(3), the Attorney General is authorized 
to suspend or revoke a registration issued under 21 U.S.C. 823 ``upon a 
finding that the registrant . . . has had his State license or 
registration suspended . . . [or] revoked . . . by competent State 
authority and is no longer authorized by State law to engage in the . . 
. dispensing of controlled substances.'' With respect to a 
practitioner, DEA has also long held that the possession of authority 
to dispense controlled substances under the laws of the state in which 
a practitioner engages in professional practice is a fundamental 
condition for obtaining and maintaining a practitioner's registration. 
Gonzales v. Oregon, 546 U.S. 243, 270 (2006) (``The Attorney General 
can register a physician to dispense controlled substances `if the 
applicant is authorized to dispense . . . controlled substances under 
the laws of the State in which he practices.' . . . The very definition 
of a `practitioner' eligible to prescribe includes physicians 
`licensed, registered, or otherwise permitted, by the United States or 
the jurisdiction in which he practices' to dispense controlled 
substances. Sec.  802(21).''). The Agency has applied these principles 
consistently. See, e.g., James L. Hooper, M.D., 76 FR 71371, 71372 
(2011), pet. for rev. denied, 481 F. App'x 826 (4th Cir. 2012); 
Frederick Marsh Blanton, M.D., 43 FR 27616, 27617 (1978).\4\
---------------------------------------------------------------------------

    \4\ This rule derives from the text of two provisions of the 
CSA. First, Congress defined the term ``practitioner'' to mean ``a 
physician . . . or other person licensed, registered, or otherwise 
permitted, by . . . the jurisdiction in which he practices . . . , 
to distribute, dispense, . . . [or] administer . . . a controlled 
substance in the course of professional practice.'' 21 U.S.C. 
802(21). Second, in setting the requirements for obtaining a 
practitioner's registration, Congress directed that ``[t]he Attorney 
General shall register practitioners . . . if the applicant is 
authorized to dispense . . . controlled substances under the laws of 
the State in which he practices.'' 21 U.S.C. 823(g)(1). Because 
Congress has clearly mandated that a practitioner possess state 
authority in order to be deemed a practitioner under the CSA, DEA 
has held repeatedly that revocation of a practitioner's registration 
is the appropriate sanction whenever he is no longer authorized to 
dispense controlled substances under the laws of the state in which 
he practices. See, e.g., James L. Hooper, M.D., 76 FR 71371-72; 
Sheran Arden Yeates, M.D., 71 FR 39130, 39131 (2006); Dominick A. 
Ricci, M.D., 58 FR 51104, 51105 (1993); Bobby Watts, M.D., 53 FR 
11919, 11920 (1988); Frederick Marsh Blanton, M.D., 43 FR 27617.
---------------------------------------------------------------------------

    According to Colorado statute, ``dispense'' means ``to deliver a 
controlled substance to an ultimate user,

[[Page 9170]]

patient, or research subject by or pursuant to the lawful order of a 
practitioner, including the prescribing, administering, packaging, 
labeling, or compounding necessary to prepare the substance for that 
delivery.'' Colo. Rev. Stat. section 18-18-102(9) (2024). Further, a 
``practitioner'' means a ``physician . . . or other person licensed, 
registered, or otherwise permitted, by this state, to distribute, 
dispense, conduct research with respect to, administer, or to use in 
teaching or chemical analysis, a controlled substance in the course of 
professional practice or research.'' Id. section 18-18-102(29).
    Here, the undisputed evidence in the record is that Registrant 
lacks authority to practice as a dentist in Colorado. As discussed 
above an individual must be a licensed practitioner to dispense a 
controlled substance in Colorado. Thus, because Registrant lacks 
authority to practice as a dentist in Colorado and, therefore, is not 
authorized to handle controlled substances in Colorado, Registrant is 
not eligible to maintain a DEA registration. Accordingly, the Agency 
will order that Registrant's DEA registration be revoked.

Order

    Pursuant to 28 CFR 0.100(b) and the authority vested in me by 21 
U.S.C. 824(a), I hereby revoke DEA Certificate of Registration No. 
FC0032348, issued to James T. Craig, D.D.S. Further, pursuant to 28 CFR 
0.100(b) and the authority vested in me by 21 U.S.C. 823(g)(1), I 
hereby deny any pending applications of James T. Craig, D.D.S., to 
renew or modify this registration, as well as any other pending 
application of James T. Craig, D.D.S., for additional registration in 
Colorado. This Order is effective March 10, 2025.

Signing Authority

    This document of the Drug Enforcement Administration was signed on 
January 31, 2025, by Acting Administrator Derek Maltz. That document 
with the original signature and date is maintained by DEA. For 
administrative purposes only, and in compliance with requirements of 
the Office of the Federal Register, the undersigned DEA Federal 
Register Liaison Officer has been authorized to sign and submit the 
document in electronic format for publication, as an official document 
of DEA. This administrative process in no way alters the legal effect 
of this document upon publication in the Federal Register.

Heather Achbach,
Federal Register Liaison Officer, Drug Enforcement Administration.
[FR Doc. 2025-02341 Filed 2-6-25; 8:45 am]
BILLING CODE 4410-09-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.